NFL Launches Investigation Into Jalen Hurts’ Blood Clot Diagnosis and Medical Care

Jalen Hurts’ blood clots raise questions over medical care© Instagram/ @jalenhurts

The NFL is now looking into how the Philadelphia Eagles handled Jalen Hurts' health scare. The league and the NFL Players Association announced a joint review Sunday, after the quarterback was shut down for the rest of the season. What began as a blood clot in his leg later reached his lungs, where doctors found more. The union had pushed for answers, and now it has them. Here is where things stand and what could come next.

Jalen Hurts blood clot investigation: what the NFL and NFLPA said

The two groups kept their public message short. Their joint statement reads, “The NFL and NFL Players Association are working together to review the matter.”

That sentence took some pressure to produce. Last week, the NFLPA demanded a full inquiry into how Hurts' medical care was managed. The union laid out its position in clear terms.

“Before conclusions are drawn about how this situation was handled, there must be a full investigation into what occurred. Determining the facts is essential to ensuring players receive the highest level of care and protection going forward.”

Notice what the union did not say. It did not accuse the Eagles of anything. It asked for facts first. That tone matters, because a joint review between the league and the players' union is a bigger step than a single team looking at itself.

The timeline is the heart of the matter. Hurts was first diagnosed with a superficial blood clot in his leg. The clot then spread to his lungs, and multiple clots were found there. A clot in the lungs is serious, and the gap between the first diagnosis and the later one is the sort of detail investigators will study closely.

Jalen Hurts return timeline and what it means for the Eagles

Hurts will not play again this season. TMZ reports that staying off the field is essential for him right now. Doctor David Abbasi told TMZ's "In The Know" that the quarterback could be out for 3 to 6 months. The risk, he explained, is serious damage from bleeding.

That range matters for Philadelphia. Three months would put Hurts back around the start of the offseason program. Six months would reach deep into the summer. Either way, the Eagles must plan for a long stretch without their starter and think about next year's depth chart now.

Dr. Abbasi's comments come from outside the case, so they show general risk and not Hurts' exact situation. Neither the Eagles nor Hurts' camp has shared a full medical update in the material reported so far.

For now, the focus is on the review. Players across the league will be watching closely, because the findings could shape how teams handle similar cases in the future.